Ultragenyx Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 1,378 | 0.0016% |
| State or Government | 34,853 | 0.0405% |
| Individual Insiders | 3,240,692 | 3.77% |
| Hedge Funds | 6,887,086 | 8.01% |
| Institutions | 75,816,084 | 88.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 8,673,432 | R$1.9b | 19.9% | 0.01% | |||
| 6,887,086 | R$1.5b | 27.4% | 5.41% | |||
| 5,238,400 | R$1.2b | 3.13% | no data | |||
| 4,415,029 | R$974.4m | -15% | 0.03% | |||
| 4,118,008 | R$908.9m | 59.8% | 0.45% | |||
| 3,448,698 | R$761.1m | 9.13% | 0.01% | |||
| 3,252,502 | R$717.8m | 26.7% | 0.01% | |||
| 2,724,300 | R$601.3m | -0.4% | no data | |||
| 2,446,500 | R$540.0m | 11.4% | 0.29% | |||
| 2,383,492 | R$526.1m | 3.92% | 0.08% | |||
| 2,126,306 | R$469.3m | 213% | 4.1% | |||
| 1,867,928 | R$412.3m | 14.9% | 0.64% | |||
| 1,754,038 | R$387.1m | 18.8% | 2.2% | |||
| 1,578,603 | R$348.4m | 3.01% | 0.02% | |||
| 1,489,486 | R$328.7m | 58.3% | 0.14% | |||
| 1,466,547 | R$323.7m | 7.32% | 0.81% | |||
| 1,283,622 | R$283.3m | 18.5% | no data | |||
| 1,172,866 | R$258.9m | 23.8% | 0.03% | |||
| 1,163,077 | R$256.7m | -3.21% | 0.05% | |||
| 1,025,000 | R$226.2m | 1,040% | 0.09% | |||
| 1,023,136 | R$225.8m | 17.7% | 0.03% | |||
| 992,951 | R$219.2m | -3.38% | no data | |||
| 906,494 | R$200.1m | -9.93% | 0.01% | |||
| 900,000 | R$198.6m | 0% | 1.37% | |||
| 895,662 | R$197.7m | 0% | 0.03% |